These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14 related articles for article (PubMed ID: 13350696)
1. [Uses of BZ 55: a sulfonamide derivative for oral administration]. ROOT HF; CAMERINI DAVALOS R Dia Med; 1956 Jun; 28(43):1205-16. PubMed ID: 13344309 [No Abstract] [Full Text] [Related]
2. [Oral treatment of diabetes mellitus with a sulfonamide derivative; N1-sulfanilyn-N2-n-butyl carbamide]. ANGELI G; TEDESCHI G Minerva Med; 1956 Jun; 47(50):1968-75. PubMed ID: 13348337 [No Abstract] [Full Text] [Related]
3. [Oral treatment of diabetes mellitus with N-4-methyl-benzolsulfonyl-N'-butyl-urea (D-860); clinical and experimental research]. Dtsch Med Wochenschr; 1956 Jun; 81(22):887-960; concl. PubMed ID: 13344014 [No Abstract] [Full Text] [Related]
4. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan]. FRAENKEL KA; SCHULZ K Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175 [No Abstract] [Full Text] [Related]
5. [Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action]. MOREAU R; DEUIL R; SARRAZIN A; DE TRAVERSE PM; MARTINET M Presse Med (1893); 1956 Jul; 64(54):1261-4. PubMed ID: 13350129 [No Abstract] [Full Text] [Related]
6. [A new anti-diabetic principle for oral administration]. FRANKEL PE Rev Bras Med; 1956 Apr; 13(4):267-8. PubMed ID: 13350696 [No Abstract] [Full Text] [Related]